 Role new anticoagulants adjunctive therapy thrombolysis Procoagulant activity coronary thrombolysis result delay time recanalization recurrent thrombosis heparin aspirin form mainstay current therapy recurrent thrombosis adjunctive heparin therapy thrombolysis agents thrombin antithrombin III-independent mechanisms inhibit steps coagulation cascade effective experimental preparation coronary thrombolysis heparin-antithrombin III inefficient inhibitor thrombin bound agents hirudin small peptide inhibitors thrombin-active site effective inhibitors clot-associated thrombin activity Inhibition early steps coagulation cascade inhibitor tissue factor-factor VIIa complex activated protein effective anticoagulant strategy experimental preparations agents superiority recurrent thrombosis heparin cases rate clot lysis